Marine Sponge-Derived Secondary Metabolites Modulate SARS-CoV-2 Entry Mechanisms
Hormone and Metabolic Research · 01.04.2024 · 56 (04) · 308-317
DOI: 10.1055/a-2173-0277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.04.2024. Verfasst von Charlotte Steenblock und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. Hauptthemen laut MEDLINE: COVID-19, Porifera. Die Arbeit nennt 55 Literaturangaben.
Abstract (Originalsprache)
The emergence of SARS-CoV 2 caused the COVID-19 pandemic, resulting in numerous global infections and deaths. In particular, people with metabolic diseases display an increased risk of severe COVID 19 and a fatal outcome. Treatment options for severe cases are limited, and the appearance of new virus variants complicates the development of novel therapies. To better manage viral infections like COVID 19, new therapeutic approaches are needed. Marine sponges offer a natural and renewable source of unique bioactive agents. These sponges produce secondary metabolites with various effects, including anti-viral, anti-inflammatory, and anti-tumorigenic properties. In the current study, we investigated the effect of five different marine sponge-derived secondary metabolites (four bromotyrosines and one sesquiterpenoid hydroquinone). Two of these, Avarol and Acetyl-dibromoverongiaquinol reduced the expression of ACE2, the main receptor for SARS-CoV 2, and the alternative receptor NRP1. Moreover, these substances derived from sponges demonstrated the ability to diminish the virus titer in SARS-CoV 2-infected cells, especially concerning the Omicron lineage. However, the reduction was not substantial enough to expect a significant impact on infected humans. Consequently, the investigated sponge-derived secondary metabolites are not likely to be effective to treat COVID 19 as a stand-alone therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
- Institute of Medical Microbiology and Virology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
- Center for Advanced Technologies, Adam Mickiewicz University, Poznan, Poland.
- School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom of Great Britain and Northern Ireland.
- Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zürich, Switzerland.
- Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany.
ORCID-Profile: Charlotte Steenblock
Zitieren
APA
Steenblock, C., Richter, S., Lindemann, D., Ehrlich, H., Bornstein, S. R., & Bechmann, N. (2024). Marine Sponge-Derived Secondary Metabolites Modulate SARS-CoV-2 Entry Mechanisms. Hormone and Metabolic Research, 56(04), 308-317. https://doi.org/10.1055/a-2173-0277
Vancouver
Steenblock C, Richter S, Lindemann D, Ehrlich H, Bornstein SR, Bechmann N. Marine Sponge-Derived Secondary Metabolites Modulate SARS-CoV-2 Entry Mechanisms. Hormone and Metabolic Research. 2024;56(04):308-317. doi:10.1055/a-2173-0277
BibTeX
@article{Steenblock2024,
author = {Steenblock, Charlotte and Richter, Stefanie and Lindemann, Dirk and Ehrlich, Hermann and Bornstein, Stefan R and Bechmann, Nicole},
title = {Marine Sponge-Derived Secondary Metabolites Modulate SARS-CoV-2 Entry Mechanisms},
journal = {Hormone and Metabolic Research},
year = {2024},
volume = {56},
number = {04},
pages = {308--317},
doi = {10.1055/a-2173-0277}
}
EUVIMED